by Yecuris Corporation | Dec 24, 2019
New insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. Minniti et. al., 2019 Study Summary Minniti ME, Pedrelli M, Vedin LL, Delbès AS, Denis RGP, Öörni K, Sala C, Pirazzini C, Thiagarajan D, Nurmi HJ,...
by Rob Copenhaver | Mar 11, 2019
Alirocumab Response in FRG Mice Regulation of Lipoprotein (a) Metabolism by PCSK9 in Animal Models Villard et. al., 2016 Study Summary T. T. T. Tran, E. Villard, B. Poirier, E. Guillot, JC. Le Bail, C. Boixel, D. Boulay, J. Blankenstein, A. Parkar, T. Muslin and P....
by Rob Copenhaver | Mar 6, 2019
Humanized Mouse Lipoprotein Profiling Mice with chimeric livers are an improved model for human lipoprotein metabolism Ellis et. al., 2013 – Study Summary Ellis EC, Naugler S, Parini P, Mörk LM, Jorns C, Zemack H, Sandblom AL, Björkhem I, Ericzon BG, Wilson EM,...
by Rob Copenhaver | Feb 27, 2019
Correction of Familial Hypercholesterolaemia Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model Bissig-Choisat et. al., 2015 – Study Summary Beatrice Bissig-Choisat, Lili Wang, Xavier Legras, Pradip K. Saha, Leon Chen,...
